Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis

NCT04706507 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

205

Enrollment

OTHER

Sponsor class

Stopped due to increased mortality and futility analyses

Conditions

Acute Respiratory Failure

Interventions

DRUG: IV Ganciclovir
DRUG: Normal saline

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]